Hyperbaric oxygen therapy and preconditioning for ischemic and hemorrhagic stroke

Area of Science:

• Neurology
• Oxygen Therapy
• Neurosurgery

Background:

• Current therapeutic options for ischemic and hemorrhagic stroke remain limited.
• Cerebral hypoxia is a critical factor in stroke-induced brain damage.
• Hyperbaric oxygen (HBO) therapy involves breathing pure oxygen at elevated pressures to enhance oxygen delivery.

Purpose of the Study:

• To explore the neuroprotective potential of hyperbaric oxygen (HBO) therapy in stroke.
• To review existing evidence on HBO's mechanisms and clinical applications in stroke.
• To identify the need for further translational research and clinical trials for HBO in stroke management.

Main Methods:

• Review of basic science and clinical evidence regarding HBO therapy for stroke.
• Analysis of HBO's mechanisms of action, including enhanced oxygen supply and neuroprotection.
• Assessment of the current limitations in clinical translation of HBO for stroke.

Main Results:

• Accumulated evidence suggests HBO therapy and preconditioning exert neuroprotective effects through various mechanisms.
• HBO facilitates oxygen delivery, potentially mitigating hypoxic brain injury following stroke.
• Existing research highlights HBO's therapeutic potential, but clinical translation is limited.

Conclusions:

• Hyperbaric oxygen therapy demonstrates significant neuroprotective potential for stroke patients.
• Further translational studies and robust clinical trials are essential to optimize HBO protocols.
• Establishing effective HBO treatment strategies could improve outcomes for ischemic and hemorrhagic stroke.